Kardiologie COR s.r.o.

At Kardiologie COR s.r.o. in Prague, clinical research is focused on cardiovascular diseases and the prevention of major heart and blood vessel complications. The studies are designed to assess whether new or improved treatments can lower the risk of events such as heart attack, stroke, and cardiovascular death in people at elevated risk.

• Research in atherosclerotic cardiovascular disease and related artery narrowing
• Studies in adults at high risk of major adverse cardiovascular events without prior heart attack or stroke
• Evaluation of treatments aimed at reducing coronary heart disease, myocardial infarction, and ischemic stroke

These trials are helping determine how well newer lipid-lowering and cardiovascular therapies may improve long-term outcomes for patients with significant atherosclerotic disease.

The site also contributes to research in nutritional and metabolic diseases, especially where excess weight overlaps with atherosclerotic cardiovascular disease. This work explores whether treatment strategies can improve cardiovascular health in people with overweight or obesity alongside existing heart risk.

• Trials involving ASCVD in participants with overweight or obesity
• Assessment of therapies intended to reduce cardiovascular morbidity and mortality
• Research on how metabolic risk factors influence heart and vessel disease

By examining the link between metabolic health and cardiovascular outcomes, the research aims to support better prevention and treatment approaches for patients with combined risk factors.